COVID-19 related olfactory dysfunction
K Karamali, M Elliott, C Hopkins - Current opinion in …, 2022 - journals.lww.com
COVID-19 related olfactory dysfunction : Current Opinion in Otolaryngology & Head and Neck
Surgery COVID-19 related olfactory dysfunction : Current Opinion in Otolaryngology & Head …
Surgery COVID-19 related olfactory dysfunction : Current Opinion in Otolaryngology & Head …
Olfactory and gustatory disorders in COVID-19
L Klimek, J Hagemann, J Döge… - Allergo journal …, 2022 - Springer
Loss of olfaction is one of the symptoms most commonly reported by patients with
coronavirus disease 2019 (COVID-19). Although the spontaneous recovery rate is high …
coronavirus disease 2019 (COVID-19). Although the spontaneous recovery rate is high …
[HTML][HTML] A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
Background: Sudden smell loss is a specific early symptom of COVID-19, which, prior to the
emergence of Omicron, had estimated prevalence of~ 40% to 75%. Chemosensory …
emergence of Omicron, had estimated prevalence of~ 40% to 75%. Chemosensory …
The effects of persistent olfactory and gustatory dysfunctions on quality of life in long-COVID-19 patients
LA Vaira, C Gessa, G Deiana, G Salzano, F Maglitto… - Life, 2022 - mdpi.com
(1) Background: Persistent olfactory (POD) and gustatory (PGD) dysfunctions are one of the
most frequent symptoms of long-Coronavirus Disease 2019 but their effect on the quality of …
most frequent symptoms of long-Coronavirus Disease 2019 but their effect on the quality of …
Prevalence of persistent olfactory disorders in patients with COVID-19: a psychophysical case-control study with 1-year follow-up
The purpose of this multicenter case-control study was to evaluate a group of patients at
least 1 year after coronavirus disease 2019 (COVID-19) with Sniffin'Sticks tests and to …
least 1 year after coronavirus disease 2019 (COVID-19) with Sniffin'Sticks tests and to …
New onset of smell and taste loss are common findings also in patients with symptomatic COVID‐19 after complete vaccination
The aim of this study is to investigate the clinical profile of patients who developed
coronavirus disease 2019 (COVID‐19) after full vaccination. Demographic, epidemiological …
coronavirus disease 2019 (COVID‐19) after full vaccination. Demographic, epidemiological …
[HTML][HTML] Results from psychophysical tests of smell and taste during the course of SARS-CoV-2 infection: a review
EMC Trecca, M Cassano, F Longo… - Acta …, 2022 - ncbi.nlm.nih.gov
Only a few studies have assessed smell and taste in Coronavirus Disease 2019 (COVID-19)
patients with psychophysical tests, while the majority performed self-rating evaluations …
patients with psychophysical tests, while the majority performed self-rating evaluations …
Increasing incidence of parosmia and phantosmia in patients recovering from COVID-19 smell loss
Importance Sudden smell loss is a specific early symptom of COVID-19, with an estimated
prevalence of∼ 40% to 75%. Smell impairment affects physical and mental health, and …
prevalence of∼ 40% to 75%. Smell impairment affects physical and mental health, and …
Olfactory recovery following omicron variant infection: a psychophysical prospective case–control study with six-month follow up
LA Vaira, P Boscolo-Rizzo, JR Lechien… - The Journal of …, 2023 - cambridge.org
ObjectiveThis study aimed to evaluate the recovery of olfactory function at six months in
individuals infected with the coronavirus disease 2019 omicron variant, using …
individuals infected with the coronavirus disease 2019 omicron variant, using …
Two-year follow-up on chemosensory dysfunction and adaptive immune response after infection with SARS-CoV-2 in a cohort of 44 healthcare workers
SE Schambeck, LM Mateyka, T Burrell, N Graf, I Brill… - Life, 2022 - mdpi.com
Persistent chemosensory dysfunction (PCD) is a common symptom of long-COVID.
Chemosensory dysfunction (CD) as well as SARS-CoV-2-specific antibody levels and CD8+ …
Chemosensory dysfunction (CD) as well as SARS-CoV-2-specific antibody levels and CD8+ …